Vest, L. S., Liu, M., Goyal, A., Fell, G. G., Sethi, R. K., Rettig, E. M., Uppaluri, R., Annino, D. J., Goguen, L. A., Margalit, D. N., Schoenfeld, J. D., Tishler, R. B., Stevens, J., Ran, N., Yoon, C., DeSimone, M., Ruiz, E. S., Cohen, J., Silk, A. W., Khaddour, K. (2026). Circulating tumor DNA (ctDNA) as a biomarker for pathologic response and clinical outcomes in patients with cutaneous squamous cell carcinoma (CSCC) receiving neoadjuvant anti–PD-1 therapy.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.9587